American Journal of Cardiology
Volume 104, Issue 4 , Pages 559-564 , 15 August 2009

Relation of N-Terminal Pro-B-Type Natriuretic Peptide to Symptoms, Severity, and Left Ventricular Remodeling in Patients With Organic Mitral Regurgitation

  • Mihael Potocki, MD

      Affiliations

    • Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
    • Corresponding Author InformationCorresponding author: Tel: 41-612652525; fax: 41-612655353
    • ,
  • Johannes Mair, MD

      Affiliations

    • Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria
    • ,
  • Michael Weber, MD

      Affiliations

    • Department of Cardiology, Kerckhoff Klinik, Bad Nauheim, Germany
    • ,
  • Christian Hamm, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
    • ,
  • Thilo Burkard, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
    • ,
  • Renate Hiemetzberger, MD

      Affiliations

    • Department of Cardiology, Innsbruck Medical University, Innsbruck, Austria
    • ,
  • Klaus Peters, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • Nikolaus Jander, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • Thomas A. Cron, MD

      Affiliations

    • Basel, Switzerland
    • ,
  • Niklaus Hess, MD

      Affiliations

    • Basel, Switzerland
    • ,
  • Andreas Hoffmann, MD

      Affiliations

    • Basel, Switzerland
    • ,
  • Helmut Gekeler, MD

      Affiliations

    • Loerrach, Germany
    • ,
  • Christa Gohlke-Bärwolf, MD

      Affiliations

    • Department of Cardiology, Herzzentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • Peter Buser, MD

      Affiliations

    • Department of Cardiology, University Hospital, Basel, Switzerland
    • ,
  • Christian Mueller, MD

      Affiliations

    • Department of Internal Medicine, University Hospital, Basel, Switzerland

Received 1 March 2009 ,Revised 13 April 2009 ,Accepted 13 April 2009.

References 

  1. Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84–e231
  2. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90:830–837
  3. Kang DH, Kim JH, Rim JH, Kim MJ, Yun SC, Song JM, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 2009;119:797–804
  4. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999;99:400–405
  5. Ross J. The timing of surgery for severe mitral regurgitation. N Engl J Med. 1996;335:1456–1458
  6. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly. 2007;137:4–12
  7. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106:416–422
  8. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647–654
  9. Gerber IL, Stewart RA, Legget ME, West TM, French RL, Sutton TM, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation. 2003;107:1884–1890
  10. Brookes CI, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis. 1997;6:608–612
  11. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol. 2003;41:2280–2287
  12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463
  13. Hall SA, Brickner ME, Willett DL, Irani WN, Afridi I, Grayburn PA. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation. 1997;95:636–642
  14. Thomas L, Foster E, Hoffman JI, Schiller NB. The Mitral Regurgitation Index: an echocardiographic guide to severity. J Am Coll Cardiol. 1999;33:2016–2022
  15. Enriquez-Sarano M, Miller FA, Hayes SN, Bailey KR, Tajik AJ, Seward JB. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol. 1995;25:703–709
  16. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167–184
  17. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail. 2004;6:365–368
  18. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
  19. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–883
  20. Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–1423
  21. Borow KM, Green LH, Mann T, Sloss LJ, Braunwald E, Collins JJ, et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med. 1980;68:655–663
  22. Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation. 1994;89:191–197
  23. Zile MR, Gaasch WH, Carroll JD, Levine HJ. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol. 1984;3:235–242
  24. Flemming MA, Oral H, Rothman ED, Briesmiester K, Petrusha JA, Starling MR. Echocardiographic markers for mitral valve surgery to preserve left ventricular performance in mitral regurgitation. Am Heart J. 2000;140:476–482
  25. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation. 2005;111:2391–2397
  26. Watanabe M, Murakami M, Furukawa H, Nakahara H. Is measurement of plasma brain natriuretic peptide levels a useful test to detect for surgical timing of valve disease?. Int J Cardiol. 2004;96:21–24
  27. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–833
  28. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202
  29. Detaint D, Messika-Zeitoun D, Chen HH, Rossi A, Avierinos JF, Scott C, et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol. 2006;97:1029–1034
  30. Thomas N, Unsworth B, Ferenczi EA, Davies JE, Mayet J, Francis DP. Intraobserver variability in grading severity of repeated identical cases of mitral regurgitation. Am Heart J. 2008;156:1089–1094

 This study was supported by research grants from the Swiss National Science Foundation, Bern, Switzerland; the Swiss Heart Foundation, Bern, Switzerland; the Department of Internal Medicine, University Hospital, Basel, Switzerland; and Roche Diagnostics, Rotkreuz, Switzerland.

PII: S0002-9149(09)00927-8

doi: 10.1016/j.amjcard.2009.04.023

American Journal of Cardiology
Volume 104, Issue 4 , Pages 559-564 , 15 August 2009

Article Tools

* Image Usage & Resolution